Follow
Joseph P. Schacht
Joseph P. Schacht
Associate Professor of Psychiatry, University of Colorado School of Medicine
Verified email at cuanschutz.edu - Homepage
Title
Cited by
Cited by
Year
Functional neuroimaging studies of alcohol cue reactivity: a quantitative meta‐analysis and systematic review
JP Schacht, RF Anton, H Myrick
Addiction biology 18 (1), 121-133, 2013
5712013
Marijuana craving in the brain
FM Filbey, JP Schacht, US Myers, RS Chavez, KE Hutchison
Proceedings of the National Academy of Sciences 106 (31), 13016-13021, 2009
2652009
Neural substrates of cue reactivity: association with treatment outcomes and relapse
KE Courtney, JP Schacht, K Hutchison, DJO Roche, LA Ray
Addiction biology 21 (1), 3-22, 2016
2152016
Marijuana withdrawal and craving: influence of the cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase (FAAH) genes
HM Haughey, E Marshall, JP Schacht, A Louis, KE Hutchison
Addiction 103 (10), 1678-1686, 2008
1652008
Associations between cannabinoid receptor-1 (CNR1) variation and hippocampus and amygdala volumes in heavy cannabis users
JP Schacht, KE Hutchison, FM Filbey
Neuropsychopharmacology 37 (11), 2368-2376, 2012
1422012
Individual and additive effects of the CNR1 and FAAH genes on brain response to marijuana cues
FM Filbey, JP Schacht, US Myers, RS Chavez, KE Hutchison
Neuropsychopharmacology 35 (4), 967-975, 2010
1382010
The incentive salience of alcohol: translating the effects of genetic variant in CNR1
KE Hutchison, H Haughey, M Niculescu, J Schacht, A Kaiser, J Stitzel, ...
Archives of general psychiatry 65 (7), 841-850, 2008
1142008
COMT val158met moderation of dopaminergic drug effects on cognitive function: a critical review
JP Schacht
The pharmacogenomics journal 16 (5), 430-438, 2016
1102016
Predictors of naltrexone response in a randomized trial: reward-related brain activation, OPRM1 genotype, and smoking status
JP Schacht, PK Randall, PK Latham, KE Voronin, SW Book, H Myrick, ...
Neuropsychopharmacology 42 (13), 2640-2653, 2017
972017
Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues
JP Schacht, RF Anton, KE Voronin, PK Randall, X Li, S Henderson, ...
Neuropsychopharmacology 38 (3), 414-422, 2013
942013
Stability of fMRI striatal response to alcohol cues: a hierarchical linear modeling approach
JP Schacht, RF Anton, PK Randall, X Li, S Henderson, H Myrick
Neuroimage 56 (1), 61-68, 2011
852011
Intermediate cannabis dependence phenotypes and the FAAH C385A variant: an exploratory analysis
JP Schacht, RE Selling, KE Hutchison
Psychopharmacology 203, 511-517, 2009
762009
Varenicline effects on drinking, craving and neural reward processing among non-treatment-seeking alcohol-dependent individuals
JP Schacht, RF Anton, PK Randall, X Li, S Henderson, H Myrick
Psychopharmacology 231, 3799-3807, 2014
532014
A methodological checklist for fMRI drug cue reactivity studies: development and expert consensus
H Ekhtiari, M Zare-Bidoky, A Sangchooli, AC Janes, MJ Kaufman, ...
Nature Protocols 17 (3), 567-595, 2022
492022
Investigating a novel fMRI cannabis cue reactivity task in youth
HC Karoly, JP Schacht, LR Meredith, J Jacobus, SF Tapert, KM Gray, ...
Addictive behaviors 89, 20-28, 2019
422019
Effects of a GABA-ergic medication combination and initial alcohol withdrawal severity on cue-elicited brain activation among treatment-seeking alcoholics
JP Schacht, RF Anton, PK Randall, X Li, S Henderson, H Myrick
Psychopharmacology 227, 627-637, 2013
382013
Aripiprazole suppression of drinking in a clinical laboratory paradigm: influence of impulsivity and self‐control
RF Anton, JP Schacht, KE Voronin, PK Randall
Alcoholism: Clinical and Experimental Research 41 (7), 1370-1380, 2017
362017
Brain glutamate, GABA, and glutamine levels and associations with recent drinking in treatment‐naive individuals with alcohol use disorder versus light drinkers
JJ Prisciandaro, JP Schacht, AP Prescot, PF Renshaw, TR Brown, ...
Alcoholism: Clinical and Experimental Research 43 (2), 221-226, 2019
342019
Systematic review and meta‐analysis of the moderating effect of rs1799971 in OPRM1, the mu‐opioid receptor gene, on response to naltrexone treatment of …
EE Hartwell, R Feinn, PE Morris, J Gelernter, J Krystal, AJ Arias, ...
Addiction 115 (8), 1426-1437, 2020
332020
Nicotine‐use/smoking is associated with the efficacy of naltrexone in the treatment of alcohol dependence
RF Anton, PK Latham, KE Voronin, PK Randall, SW Book, M Hoffman, ...
Alcoholism: Clinical and Experimental Research 42 (4), 751-760, 2018
332018
The system can't perform the operation now. Try again later.
Articles 1–20